• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

CT reveals traits of drug-resistanttuberculosis

Publication
Article
Diagnostic ImagingDiagnostic Imaging Vol 31 No 6
Volume 31
Issue 6

Micronodules, tree-in-bud appearance, consolidations, cavities, bronchiectasis, and lobular consolidations are frequent CT abnormalities of extensively drug-resistant tuberculosis.

Micronodules, tree-in-bud appearance, consolidations, cavities, bronchiectasis, and lobular consolidations are frequent CT abnormalities of extensively drug-resistant tuberculosis.

Researchers at the Seoul National Hospital in Korea made the discovery after a retrospective review of tests from 260 patients diagnosed with multidrug-resistant tuberculosis from 1994 to 2005. The researchers found that 47 patients had drug-resistant TB, while 213 had multidrug-resistant TB.

CT exams of 20 of the 47 drug-resistant and 85 of the 213 multidrug-resistant TB patients revealed micronodules and tree-inbud appearance in all of them. About 70% of patients showed lobular consolidations. Cavities and bronchiectasis were also conspicuous on CT.

Drug-resistant TB is a serious public health issue in many countries. Radiologists should consider the possibility of TB upon identifying signs, Lee said. He presented the study at the 2008 RSNA meeting.

Recent Videos
How Will the New FDA Guidance Affect AI Software in Radiology?: An Interview with Nina Kottler, MD, Part 2
A Closer Look at the New Appropriate Use Criteria for Brain PET: An Interview with Phillip Kuo, MD, Part 2
How Will the New FDA Guidance Affect AI Software in Radiology?: An Interview with Nina Kottler, MD, Part 1
A Closer Look at the New Appropriate Use Criteria for Brain PET: An Interview with Phillip Kuo, MD, Part 1
Teleradiology and Breast Imaging: Keys to Facilitating Personalized Service, Efficiency and Equity
Current and Emerging Insights on AI in Breast Imaging: An Interview with Mark Traill, MD, Part 3
Current and Emerging Insights on AI in Breast Imaging: An Interview with Mark Traill, MD, Part 2
Current and Emerging Insights on AI in Breast Imaging: An Interview with Mark Traill, Part 1
Related Content
© 2025 MJH Life Sciences

All rights reserved.